Medical Research
Soligenix Inc. Achieves Significant Milestone in Phase 2a Study for Behçet’s Disease Treatment
Soligenix Inc. reports promising results from its Phase 2a study of SGX945 for Behçet’s Disease, showing potential to address unmet medical needs in inflammatory conditions.
Lantern Pharma Achieves Milestone in Phase 2 HARMONIC Trial for Non-Smoker NSCLC Patients in Japan
Lantern Pharma completes targeted enrollment for its Phase 2 HARMONIC trial in Japan, marking a significant step in its international expansion and offering hope for never-smoker NSCLC patients.
BTT Brain Wellness Institute Pioneers Non-Invasive Brain Health Solutions
The BTT Brain Wellness Institute, founded by Dr. M. Marc Abreu, introduces innovative, non-invasive treatments to optimize brain function, marking a significant advancement in personalized brain health care.
American Heart Association Recognizes Nearly 5,000 Organizations for Excellence in Cardiovascular Care
The American Heart Association has recognized 4,859 organizations for their commitment to improving cardiovascular care, highlighting the importance of evidence-based treatments in reducing deaths from heart disease and stroke.
GeoVax Accelerates GEO-MVA Vaccine Development Amid Global Mpox Crisis
GeoVax Labs, Inc. is expediting the development of its GEO-MVA Mpox vaccine in response to a global surge in cases and the WHO's reaffirmation of Mpox as a public health emergency, highlighting the urgent need for scalable and equitable vaccine solutions.
American Heart Association Expands Initiative to Combat Cardiovascular-Kidney-Metabolic Syndrome Across 15 U.S. Regions
The American Heart Association's expansion of its Cardiovascular-Kidney-Metabolic Health Initiative to 15 U.S. regions aims to address the interconnected conditions leading to heart disease and stroke, marking a significant step in public health intervention.
Aditxt Inc. Subsidiary Pearsanta Advances in DoD-Funded Ovarian Cancer Diagnostic Study
Aditxt Inc.'s subsidiary Pearsanta moves forward in a Department of Defense-funded study for early ovarian cancer detection, highlighting the potential impact on women's health diagnostics.
Candel Therapeutics' CAN-2409 Receives European Orphan Designation for Pancreatic Cancer Treatment
The European Medicines Agency grants Orphan Designation to Candel Therapeutics' CAN-2409, highlighting its potential to address the significant unmet medical need in pancreatic cancer treatment across Europe.
New Book Sheds Light on Gut Health's Role in Chronic Conditions
A new book by Dr. Kristin Kidgell and Ruth Brooks explores the connection between gut health and chronic illnesses, offering a science-backed approach to healing.
Community Health Centers Expand Screening for Cardiovascular Disease Marker Lp(a)
The American Heart Association's initiative to screen for lipoprotein(a) in community health centers aims to reduce cardiovascular disease risk by identifying inherited risk factors early.
Donna White to Spotlight Hormone Health at South Florida Event Following FDA Roundtable
Donna White, a leading expert in bioidentical hormone replacement therapy, will address the future of hormone health at a South Florida event, highlighting the importance of informed healthcare decisions.
CLL Society Honors Innovators in Leukemia and Lymphoma Research
The CLL Society has awarded three researchers for their innovative projects aimed at improving care and outcomes for patients with chronic lymphocytic leukemia and small lymphocytic lymphoma, highlighting the importance of integrative medicine, clinical research, and overcoming treatment resistance.
Study Reveals Early Health Visits May Predict Multiple Sclerosis Decades Before Diagnosis
A recent study indicates that individuals later diagnosed with multiple sclerosis visit healthcare providers more frequently decades before their diagnosis, suggesting potential for earlier intervention.
Soligenix Inc. Reports Promising Results in HyBryte(TM) Trial for Early-Stage Cutaneous T-Cell Lymphoma
Soligenix Inc.'s HyBryte(TM) shows promising treatment success in early-stage cutaneous T-cell lymphoma, offering hope for patients with limited options.
SeaStar Medical and AREVA Institute Collaborate on Innovative Burn Treatment Research with DoD Grant
A $2 million DoD grant supports SeaStar Medical and AREVA Institute's research into SCD therapy for reducing hyperinflammation in severe burns, potentially revolutionizing treatment for military and civilian patients.
Study Links Heart Scar Tissue to Dangerous Rhythms in Older Male Athletes
A U.K. study finds scar tissue in the heart may increase the risk of dangerous heart rhythms in healthy, long-time male endurance athletes over 50, highlighting the importance of monitoring and safety measures in sports.
Study Reveals Significant Proportion of Lung Cancer Patients Are Non-Smokers
Recent research highlights the puzzling prevalence of lung cancer among non-smokers, prompting urgent calls for further study and treatment development.
BioRestorative Therapies Reports Promising Phase 2 Trial Results for Chronic Pain Treatment
BioRestorative Therapies' phase 2 trial results for BRTX-100 show significant improvement in function and pain reduction for chronic lumbar disc disease patients, potentially paving the way for accelerated FDA approval.
Leading Health Experts Join American Heart Association Board to Combat Cardiovascular Diseases
The American Heart Association strengthens its leadership with the appointment of Dr. Jennifer Ashton and Dr. Joseph Woo to its Board of Directors, aiming to enhance cardiovascular and cerebrovascular health outcomes.
Heart-Healthy Habits Linked to Comprehensive Body Health Benefits
A decade-long review reveals that adhering to the American Heart Association’s Life’s Simple 7™ metrics for ideal cardiovascular health is associated with improved function across multiple bodily systems, underscoring the far-reaching benefits of heart-healthy lifestyles.
Community Foundation of Broward Awards $900,000 in Grants for Cancer Research
The Community Foundation of Broward has awarded two grants totaling $900,000 to support innovative cancer research and treatment accessibility in Broward County, focusing on lung cancer biomarkers and melanoma immunotherapies.
Kairos Pharma Ltd. Reports Positive Safety Results in Phase 2 Study of Prostate Cancer Drug ENV-105
Kairos Pharma Ltd. announces favorable interim safety results from its Phase 2 trial of ENV-105 for metastatic castration-resistant prostate cancer, marking a significant step forward in cancer therapy.
Lorati's Nano-Emulsion Offers New Hope for Stroke Recovery
Lorati Co., Ltd. introduces a natural, mineral-based nano-emulsion therapy that promises a non-invasive solution for full recovery from both hemorrhagic and ischemic strokes, marking a significant advancement in stroke treatment.
NanoViricides Advances MPox Treatment with Adaptive Clinical Trial Design
NanoViricides, Inc. nears finalization of an adaptive clinical trial protocol for NV-387, a potential first-in-class treatment for MPox, highlighting its significance amid limited effective therapies.
SeaStar Medical's QUELIMMUNE Recognized by National Kidney Foundation for Innovation in Pediatric AKI Treatment
SeaStar Medical's QUELIMMUNE device, designed to treat pediatric acute kidney injury, has been awarded the 2025 Corporate Innovator Award by the National Kidney Foundation, highlighting its potential to significantly reduce mortality rates and improve quality of life for affected children.
Study Links Traumatic Brain Injuries to Increased Brain Cancer Risk in Veterans
A recent study published in JAMA Network reveals that military veterans with traumatic brain injuries face a significantly higher risk of developing brain cancer, highlighting the urgent need for advanced treatments and preventive measures.
Fifty 1 Labs and UAV Corp Complete Historic REVIVE Trial, Pioneering Long COVID Treatment
Fifty 1 Labs, Inc. and UAV Corp have successfully completed the REVIVE Adaptive Platform Trial, marking a significant advancement in the treatment of Long COVID and positioning the companies for growth in the functional medicine market.
CNS Pharmaceuticals Inc. Showcases Lead Cancer Treatment Program in Virtual CEO Segment
CNS Pharmaceuticals Inc. (NASDAQ: CNSP) emphasizes its lead cancer treatment program during a virtual CEO segment, highlighting potential advancements in brain and central nervous system cancer therapies.
University of Sydney Researchers Discover Potential Breakthrough in Parkinson's Treatment
A preclinical study by University of Sydney researchers has successfully reversed Parkinson's-like symptoms in mice by targeting a malfunctioning protein, offering hope for future human treatments.
Quantum BioPharma Submits MS Drug Candidate to UK's ILAP Program
Quantum BioPharma Ltd. advances its multiple sclerosis treatment, Lucid-MS, through the UK's Innovative Licensing and Access Pathway, aiming to accelerate patient access to this innovative therapy.